While the federal government of Germany does not dare to change cannabis laws, cities like Berlin and Düsseldorf are taking over the lead in reform. We interviewed Georg Wurth, the chairman of the German Cannabis Association about the situation.
In February 2016, Macedonia legalised medicinal cannabis but the law is far from ideal. Drugreporter’s Macedonian partner, Healthy Options Project Skopje – HOPS – carried out an analysis of the law. Read their key remarks and recommendations presented by Vlatko Dekov.
Marco Perduca is a leading cannabis reform advocate in Italy and he was one of the first civil society representative who spoke up against the drug conventions at the UN Commission on Narcotic Drugs. We interviewed him about the prospects of cannabis law reform in Italy.
In June 2016, an amendment to the Bulgarian Narcotic Substances and Precursors Control Act came into force. Read the notes of an eye-witness.
Every cannabis smoker knows that the major psychoactive ingredient of the plant is Δ9-tetrahydrocannabinol (THC), but there is also a range of other chemicals in marijuana smoke. One of the other significant components is cannabidiol (CBD). Anecdotal evidence suggests that CBD can inhibit some negative side effects associated with marijuana, but does this claim stand […]
Leading national and international experts and activists discussed barriers and opportunities at the first conference on medical cannabis in Hungary.
A struggle for making medical cannabis legal in Poland: an article by Iga Jeziorska on our new video produced by Paweł Libera and the Polish Drug Policy Network.
Medical cannabis activists formed an alliance with a political party, in order to contest the parliamentary elections in Serbia. Read Irena Molnar’s report from Belgrade, and watch the video!
After a long gestation, the UN drug reform experiment suffered a miscarriage. It seems the UN is not the catalyst of change but its mirror. Reformers can learn many lessons – but can also be proud of their achievements.
The UN General Assembly Special Session on Drugs (UNGASS) adopted the outcome document without a debate, right before the real discussion could have started.